Bulk Manufacturer of Controlled Substances Application: Alcami Wisconsin Corporation, 2675 [2018-00709]
Download as PDF
<![CDATA[
2675
Federal Register / Vol. 83, No. 12 / Thursday, January 18, 2018 / Notices
Controlled substance
Drug code
Dihydrocodeine ................................................................................................................................................................
Oxycodone .......................................................................................................................................................................
Hydromorphone ...............................................................................................................................................................
Diphenoxylate ..................................................................................................................................................................
Ecgonine ..........................................................................................................................................................................
Ethylmorphine ..................................................................................................................................................................
Hydrocodone ...................................................................................................................................................................
Levomethorphan ..............................................................................................................................................................
Levorphanol .....................................................................................................................................................................
Isomethadone ..................................................................................................................................................................
Meperidine .......................................................................................................................................................................
Meperidine intermediate-A ..............................................................................................................................................
Meperidine intermediate-B ..............................................................................................................................................
Meperidine intermediate-C ..............................................................................................................................................
Methadone .......................................................................................................................................................................
Methadone intermediate ..................................................................................................................................................
Metopon ...........................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ..............................................................................................................
Morphine ..........................................................................................................................................................................
Thebaine ..........................................................................................................................................................................
Dihydroetorphine .............................................................................................................................................................
Levo-alphacetylmethadol .................................................................................................................................................
Oxymorphone ..................................................................................................................................................................
Noroxymorphone .............................................................................................................................................................
Phenazocine ....................................................................................................................................................................
Thiafentanil ......................................................................................................................................................................
Piminodine .......................................................................................................................................................................
Racemethorphan .............................................................................................................................................................
Racemorphan ..................................................................................................................................................................
Alfentanil ..........................................................................................................................................................................
Remifentanil .....................................................................................................................................................................
Sufentanil .........................................................................................................................................................................
Carfentanil .......................................................................................................................................................................
Tapentadol .......................................................................................................................................................................
Bezitramide ......................................................................................................................................................................
Fentanyl ...........................................................................................................................................................................
Moramide-intermediate ....................................................................................................................................................
The company plans to manufacture
small quantities of the listed controlled
substances in bulk for distribution to its
customers.
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
Dated: January 5, 2018.
Susan A. Gibson,
Deputy Assistant Administrator.
SUPPLEMENTARY INFORMATION:
[FR Doc. 2018–00710 Filed 1–17–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Alcami
Wisconsin Corporation
sradovich on DSK3GMQ082PROD with NOTICES
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before March 19, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
DATES:
VerDate Sep<11>2014
18:27 Jan 17, 2018
Jkt 244001
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on July 4,
2017, Alcami Wisconsin Corporation,
W130 N10497 Washington Drive,
Germantown, Wisconsin 53022 applied
to be registered as a bulk manufacturer
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
9120
9143
9150
9170
9180
9190
9193
9210
9220
9226
9230
9232
9233
9234
9250
9254
9260
9273
9300
9333
9334
9648
9652
9668
9715
9729
9730
9732
9733
9737
9739
9740
9743
9780
9800
9801
9802
Schedule
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
of thebaine (9333), a basic class of
controlled substance listed in schedule
II.
The company states they plan to
conduct clinical trials.
Dated: January 5, 2018.
Susan A. Gibson,
Deputy Assistant Administrator.
[FR Doc. 2018–00709 Filed 1–17–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Notice of Proposed Settlement
Agreement Under the Oil Pollution Act
On January 9, 2018, a fully-executed
proposed Settlement Agreement was
received by the Department of Justice,
among the United States on behalf of the
U.S. Department of the Interior, U.S.
Fish and Wildlife Service (‘‘FWS’’), the
State of Georgia, on behalf of the
Georgia Department of Natural
Resources (‘‘GDNR’’), and Fukunaga
Kaiun Co., Ltd., a Japanese company
that was the former operator of the
Motor Vessel Fortune Epoch in
November 2004.
E:\FR\FM\18JAN1.SGM
18JAN1
]]>Agencies
[Federal Register Volume 83, Number 12 (Thursday, January 18, 2018)]
[Notices]
[Page 2675]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-00709]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Alcami
Wisconsin Corporation
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before March 19, 2018.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on July
4, 2017, Alcami Wisconsin Corporation, W130 N10497 Washington Drive,
Germantown, Wisconsin 53022 applied to be registered as a bulk
manufacturer of thebaine (9333), a basic class of controlled substance
listed in schedule II.
The company states they plan to conduct clinical trials.
Dated: January 5, 2018.
Susan A. Gibson,
Deputy Assistant Administrator.
[FR Doc. 2018-00709 Filed 1-17-18; 8:45 am]
BILLING CODE 4410-09-P
